NAS:JYNT (USA) Also trade in: Germany

The Joint Corp

$ 17.25 -1.22 (-6.61%)
Volume: 372,330 Avg Vol (1m): 140,965
Market Cap $: 237.79 Mil Enterprise Value $: 230.78 Mil
P/E (TTM): 143.75 P/B: 118.98
Earnings Power Value -1.86
Net Current Asset Value -1.47
Tangible Book -0.23
Projected FCF 0
Median P/S Value 8.04
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
YTD (-%)

Financial Strength : 6/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 7.52
Cash-To-Debt ranked higher than
72.99% of 274 companies
in the Medical Care industry.
Industry Max: 10000, Med: 0.28, Min: 0.01
JYNT: 7.52
Ranked among companies with meaningful Cash-To-Debt only.
Cash-To-Debt range over the past 10 years
Min: 2.29, Med: 10.66, Max: 10000
Current: 7.52
2.29
10000
Equity-to-Asset 0.06
Equity-to-Asset ranked lower than
76.58% of 269 companies
in the Medical Care industry.
Industry Max: 0.97, Med: 0.48, Min: -15.93
JYNT: 0.06
Ranked among companies with meaningful Equity-to-Asset only.
Equity-to-Asset range over the past 10 years
Min: -0.17, Med: 0.3, Max: 0.62
Current: 0.06
-0.17
0.62
Debt-to-Equity 0.52
Debt-to-Equity ranked higher than
80.69% of 202 companies
in the Medical Care industry.
Industry Max: 25.64, Med: 0.64, Min: 0.01
JYNT: 0.52
Ranked among companies with meaningful Debt-to-Equity only.
Debt-to-Equity range over the past 10 years
Min: 0.02, Med: 0.21, Max: 1.04
Current: 0.52
0.02
1.04
Debt-to-EBITDA 0.28
Debt-to-EBITDA ranked lower than
100.00% of 201 companies
in the Medical Care industry.
Industry Max: 66.84, Med: 2.81, Min: 0.01
JYNT: 0.28
Ranked among companies with meaningful Debt-to-EBITDA only.
Debt-to-EBITDA range over the past 10 years
Min: -1.23, Med: -0.05, Max: 0.47
Current: 0.28
-1.23
0.47
Piotroski F-Score 6
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.49
DISTRESS
GREY
SAFE
Beneish M-Score -2.72
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 0%
WACC 4.54%

Profitability & Growth : 6/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 6.47
Operating Margin ranked lower than
92.65% of 272 companies
in the Medical Care industry.
Industry Max: 66.83, Med: 6.83, Min: -3742
JYNT: 6.47
Ranked among companies with meaningful Operating Margin only.
Operating Margin range over the past 10 years
Min: -67.34, Med: -22.86, Max: 7.39
Current: 6.47
-67.34
7.39
Net Margin % 4.50
Net Margin ranked lower than
91.91% of 272 companies
in the Medical Care industry.
Industry Max: 202.55, Med: 3.88, Min: -4897.7
JYNT: 4.5
Ranked among companies with meaningful Net Margin only.
Net Margin range over the past 10 years
Min: -73.93, Med: -26.43, Max: 4.5
Current: 4.5
-73.93
4.5
ROE % 97.47
ROE ranked lower than
96.86% of 255 companies
in the Medical Care industry.
Industry Max: 73.04, Med: 8.03, Min: -4811.69
JYNT: 97.47
Ranked among companies with meaningful ROE only.
ROE range over the past 10 years
Min: -109.94, Med: -48.46, Max: 97.47
Current: 97.47
-109.94
97.47
ROA % 6.97
ROA ranked lower than
96.70% of 273 companies
in the Medical Care industry.
Industry Max: 52.42, Med: 3.48, Min: -3383.78
JYNT: 6.97
Ranked among companies with meaningful ROA only.
ROA range over the past 10 years
Min: -60.19, Med: -15.85, Max: 6.97
Current: 6.97
-60.19
6.97
ROC (Joel Greenblatt) % 61.75
ROC (Joel Greenblatt) ranked lower than
94.12% of 272 companies
in the Medical Care industry.
Industry Max: 8470.37, Med: 14.91, Min: -33236.56
JYNT: 61.75
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
ROC (Joel Greenblatt) range over the past 10 years
Min: -585.65, Med: -193.66, Max: 139.68
Current: 61.75
-585.65
139.68
3-Year Total Revenue Growth Rate 32.00
3-Year Revenue Growth Rate ranked higher than
83.89% of 211 companies
in the Medical Care industry.
Industry Max: 314.7, Med: 6.5, Min: -100
JYNT: 18
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
3-Year Revenue Growth Rate range over the past 10 years
Min: 9.3, Med: 15.5, Max: 33.6
Current: 18
9.3
33.6

» JYNT's 30-Y Financials

Financials (Next Earnings Date: 2019-08-09)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:JYNT

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Health Care Providers » Medical Care    NAICS : 621310    SIC : 8041
Compare ISX:SAME BKK:RJH-R ASX:VRT HKSE:03869 SGX:5WA NAS:BIOS NSE:HCG NAS:CATS HKSE:03689 BKK:TNH-R HKSE:00286 BKK:PR9 BOM:540797 NSE:MAXINDIA NAS:AVCO ATH:IASO KUW:MIDAN BKK:NTV HKSE:01509 OHEL:PIHLIS
Traded in other countries 1JO.Germany
Address 16767 N. Perimeter Drive, Suite 240, Scottsdale, AZ, USA, 85260
The Joint Corp develops, owns, operates, supports and manages chiropractic clinics through direct ownership, management arrangements, franchising and the sale of regional developer rights throughout the United States. The Company has two operating business segments. The Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics. The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The Joint generates most of its revenues from its Franchise operations segment.

Ratios

Current vs industry vs history
PE Ratio (TTM) 143.75
PE Ratio ranked lower than
100.00% of 198 companies
in the Medical Care industry.
Industry Max: 6430, Med: 27.31, Min: 1.39
JYNT: 143.75
Ranked among companies with meaningful PE Ratio only.
PE Ratio range over the past 10 years
Min: 102.39, Med: 163.68, Max: 242.89
Current: 143.75
102.39
242.89
Forward PE Ratio 81.97
Forward P/E ranked lower than
100.00% of 59 companies
in the Medical Care industry.
Industry Max: 107.53, Med: 20.66, Min: 8.31
JYNT: 81.97
Ranked among companies with meaningful Forward P/E only.
N/A
PE Ratio without NRI 143.75
PE without NRI ranked lower than
100.00% of 198 companies
in the Medical Care industry.
Industry Max: 6430, Med: 9999, Min: 1.39
JYNT: 143.75
Ranked among companies with meaningful PE without NRI only.
PE without NRI range over the past 10 years
Min: 102.39, Med: 163.68, Max: 242.89
Current: 143.75
102.39
242.89
Price-to-Owner-Earnings 70.12
Price-to-Owner-Earnings ranked lower than
100.00% of 109 companies
in the Medical Care industry.
Industry Max: 8000, Med: 26.64, Min: 1.5
JYNT: 70.12
Ranked among companies with meaningful Price-to-Owner-Earnings only.
Price-to-Owner-Earnings range over the past 10 years
Min: 35.34, Med: 68.37, Max: 115.66
Current: 70.12
35.34
115.66
PB Ratio 118.98
PB Ratio ranked lower than
98.02% of 253 companies
in the Medical Care industry.
Industry Max: 48, Med: 2.64, Min: 0.05
JYNT: 118.98
Ranked among companies with meaningful PB Ratio only.
PB Ratio range over the past 10 years
Min: 1.76, Med: 8.86, Max: 132.34
Current: 118.98
1.76
132.34
PS Ratio 6.92
PS Ratio ranked lower than
67.18% of 262 companies
in the Medical Care industry.
Industry Max: 79.41, Med: 1.7, Min: 0.03
JYNT: 6.92
Ranked among companies with meaningful PS Ratio only.
PS Ratio range over the past 10 years
Min: 1.32, Med: 3.23, Max: 11.31
Current: 6.92
1.32
11.31
Price-to-Free-Cash-Flow 72.17
Price-to-Free-Cash-Flow ranked lower than
100.00% of 135 companies
in the Medical Care industry.
Industry Max: 777.22, Med: 23.01, Min: 1.25
JYNT: 72.17
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
Price-to-Free-Cash-Flow range over the past 10 years
Min: 26.73, Med: 70.8, Max: 209.09
Current: 72.17
26.73
209.09
Price-to-Operating-Cash-Flow 42.39
Price-to-Operating-Cash-Flow ranked lower than
100.00% of 186 companies
in the Medical Care industry.
Industry Max: 1706.9, Med: 14.67, Min: 0.7
JYNT: 42.39
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 19.71, Med: 41.58, Max: 95.83
Current: 42.39
19.71
95.83
EV-to-EBIT 100.93
EV-to-EBIT ranked lower than
100.00% of 214 companies
in the Medical Care industry.
Industry Max: 3101.61, Med: 21.68, Min: 1.06
JYNT: 100.93
Ranked among companies with meaningful EV-to-EBIT only.
EV-to-EBIT range over the past 10 years
Min: -14519.8, Med: -7.3, Max: 137.2
Current: 100.93
-14519.8
137.2
EV-to-EBITDA 60.42
EV-to-EBITDA ranked lower than
100.00% of 228 companies
in the Medical Care industry.
Industry Max: 1827.89, Med: 15.23, Min: 0.9
JYNT: 60.42
Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA range over the past 10 years
Min: -78, Med: -4.4, Max: 876.1
Current: 60.42
-78
876.1
EV-to-Revenue 6.50
EV-to-Revenue ranked lower than
61.99% of 271 companies
in the Medical Care industry.
Industry Max: 158.19, Med: 2.17, Min: 0.06
JYNT: 6.5
Ranked among companies with meaningful EV-to-Revenue only.
EV-to-Revenue range over the past 10 years
Min: 1.2, Med: 3.1, Max: 10.3
Current: 6.5
1.2
10.3
Current Ratio 1.00
Current Ratio ranked lower than
51.15% of 260 companies
in the Medical Care industry.
Industry Max: 13.59, Med: 1.34, Min: 0.04
JYNT: 1
Ranked among companies with meaningful Current Ratio only.
Current Ratio range over the past 10 years
Min: 0.97, Med: 1.38, Max: 5.54
Current: 1
0.97
5.54
Quick Ratio 1.00
Quick Ratio ranked higher than
53.08% of 260 companies
in the Medical Care industry.
Industry Max: 13.59, Med: 1.24, Min: 0.04
JYNT: 1
Ranked among companies with meaningful Quick Ratio only.
Quick Ratio range over the past 10 years
Min: 0.97, Med: 1.38, Max: 5.54
Current: 1
0.97
5.54
Days Sales Outstanding 11.13
Days Sales Outstanding ranked higher than
77.53% of 227 companies
in the Medical Care industry.
Industry Max: 524.5, Med: 39.87, Min: 0.25
JYNT: 11.13
Ranked among companies with meaningful Days Sales Outstanding only.
Days Sales Outstanding range over the past 10 years
Min: 11.13, Med: 18.18, Max: 36.16
Current: 11.13
11.13
36.16
Days Payable 97.73
Days Payable ranked higher than
66.48% of 176 companies
in the Medical Care industry.
Industry Max: 1871.61, Med: 40.58, Min: 1
JYNT: 97.73
Ranked among companies with meaningful Days Payable only.
Days Payable range over the past 10 years
Min: 33.79, Med: 121.03, Max: 258.48
Current: 97.73
33.79
258.48

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -3.10
3-Year Share Buyback Rate ranked lower than
88.68% of 159 companies
in the Medical Care industry.
Industry Max: 100, Med: -2.5, Min: -549.3
JYNT: -3.1
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
3-Year Share Buyback Rate range over the past 10 years
Min: -39.3, Med: -24.8, Max: -3.1
Current: -3.1
-39.3
-3.1

Valuation & Return

Current vs industry vs history
Price-to-Median-PS-Value 2.15
Price-to-Median-PS-Value ranked lower than
58.65% of 208 companies
in the Medical Care industry.
Industry Max: 12, Med: 1.03, Min: 0.01
JYNT: 2.15
Ranked among companies with meaningful Price-to-Median-PS-Value only.
Price-to-Median-PS-Value range over the past 10 years
Min: 0.42, Med: 1.05, Max: 3.08
Current: 2.15
0.42
3.08
Earnings Yield (Joel Greenblatt) % 0.95
Earnings Yield (Greenblatt) ranked lower than
91.58% of 273 companies
in the Medical Care industry.
Industry Max: 94.34, Med: 3.61, Min: -217.39
JYNT: 0.95
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
Earnings Yield (Greenblatt) range over the past 10 years
Min: -60.6, Med: -8.1, Max: 1.4
Current: 0.95
-60.6
1.4

More Statistics

Revenue (TTM) (Mil) $ 35.37
EPS (TTM) $ 0.12
Beta 0.36
Volatility % 54.94
52-Week Range $ 6.51 - 19.81
Shares Outstanding (Mil) 13.79

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 6
Positive ROA Y
Positive CFROA Y
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy N
Higher Asset Turnover yoy Y